These results show a direct involvement of the MAPK pathway in response to sustained NGF-TrkA signaling to attenuate the tumorigenic phenotype of MM cells by promoting proliferation arrest and support a model of negative feedback loop that may act through the up-regulation of the p21cip1 tumor suppressor (Fig. 6c). This evidence concerns the gene CDKN1A and Miyoshi myopathy.